Gallic Acid Inhibits STAT3 Phosphorylation and Alleviates DDS-induced Colitis via Regulating Cytokine Production |
Jeong, Ji Hyun
(School of Korean Medicine, Pusan National University)
Kim, Eun Yeong (School of Korean Medicine, Pusan National University) Choi, Hee Jung (Korean Medicine Research Center for Healthy Aging, Pusan National University) Chung, Tae Wook (Korean Medicine Research Center for Healthy Aging, Pusan National University) Kim, Keuk Jun (Detment of Clinical Pathology, TaeKyeung University) Kim, So Yeon (School of Korean Medicine, Pusan National University) Ha, Ki Tae (School of Korean Medicine, Pusan National University) |
1 | Jang, S.E., Hyam, S.R., Jeong, J.J., et al. Penta-O-galloyl-beta-D-glucose ameliorates inflammation by inhibiting MyD88/NF-kappaB and MyD88/MAPK signalling pathways. British journal of pharmacology 170: 1078-1091, 2013. DOI |
2 | Xiao, H.T., Lin, C.Y., Ho, D.H., et al. Inhibitory effect of the gallotannin corilagin on dextran sulfate sodium-induced murine ulcerative colitis. Journal of natural products 76: 2120-2125, 2013. DOI |
3 | Abboud, P.A., Hake, P.W., Burroughs, T.J., et al. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. European journal of pharmacology 579: 411-417, 2008. DOI |
4 | Wang, Y., Ren, X., Deng, C., et al. Mechanism of the inhibition of the STAT3 signaling pathway by EGCG. Oncology reports 30: 2691-2696, 2013. DOI |
5 | Lee, H.J., Seo, N.J., Jeong, S.J., et al. Oral administration of penta-O-galloyl-beta-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition. Carcinogenesis 32: 804-811, 2011. DOI |
6 | Hu, H., Lee, H.J., Jiang, C., et al. Penta-1,2,3,4,6-O-galloyl-beta-D-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Molecular cancer therapeutics 7: 2681-2691, 2008. DOI |
7 | Shin, J.S., Cho, E.J., Choi, H.E., et al. Anti-inflammatory effect of a standardized triterpenoid-rich fraction isolated from Rubus coreanus on dextran sodium sulfate-induced acute colitis in mice and LPS-induced macrophages. Journal of ethnopharmacology 158 Pt A: 291-300, 2014. DOI |
8 | Lin, L., Deangelis, S., Foust, E., et al. A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells. Molecular cancer 9: 217, 2010. DOI |
9 | Atreya, R., Atreya, I., Neurath, M.F. Novel signaltransduction pathways: analysis of STAT-3 and Rac-1signaling in inflammatory bowel disease. Annals of theNew York Academy of Sciences 1072: 98-113, 2006. DOI |
10 | Milner, J.D., Vogel, T.P., Forbes, L., et al. Early-onsetlymphoproliferation and autoimmunity caused bygermline STAT3 gain-of-function mutations. Blood 125:591-599, 2015. DOI |
11 | Li, Y., de Haar, C., Peppelenbosch, M.P., et al. Newinsights into the role of STAT3 in IBD. Inflammatorybowel diseases 18: 1177-1183, 2012. DOI |
12 | Li, N., Grivennikov, S.I., Karin, M. The unholy trinity: inflammation, cytokines, and STAT3 shape the cancermicroenvironment. Cancer cell 19: 429-431, 2011. DOI |
13 | Sandor, Z., Deng, X.M., Khomenko, T., et al. Altered angiogenic balance in ulcerative colitis: a key to impaired healing? Biochemical and biophysical research communications 350: 147-150, 2006. DOI |
14 | Axelsson, L.G., Landstrom, E., Goldschmidt, T.J., et al. Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice. Inflammation research : official journal of the European Histamine Research Society [et al] 45: 181-191, 1996. DOI |
15 | Bantel, H., Schulze-Osthoff, K. TNF Antagonists in IBD: Novel Antiinflammatory Mechanisms Beyond Cytokine Inhibition. Inflammatory bowel diseases 19: E51-2, 2013. DOI |
16 | Bersudsky, M., Luski, L., Fishman, D., et al. Non-redundant properties of IL-1alpha and IL-1beta during acute colon inflammation in mice. Gut 63: 598-609, 2014. DOI |
17 | Toptygina, A.P., Semikina, E.L., Bobyleva, G.V., et al. Cytokine profile in children with inflammatory bowel disease. Biochemistry Biokhimiia 79: 1371-1375, 2014. DOI |
18 | Fukuda, A., Wang, S.C., Morris, J.P.4th., et al. Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer cell 19: 441-455, 2011. DOI |
19 | Han, J., Wang, J., Wang, J.H. How to achieve deep remission in treatment of inflammatory bowel disease. Journal of Traditional Chinese Medicine, 2013. |
20 | Rahimi, R., Nikfar, S., Abdollahi, M. Induction of clinical response and remission of inflammatory bowel disease by use of herbal medicines:A meta-analysis. World Journal of Gastroenterology, 2013. |
21 | Lee, S.W., Ryu, B.H., Park, J.W. Effects of Sargassum pallidum on 2,4,6,-Tritrobenzene Sulfonic Acid-Induced Colitis in Mice. Korean J Orient Int Med 31: 224-241, 2010. DOI |
22 | Neurath, M.F. Cytokines in inflammatory bowel disease. Nature reviews Immunology 14: 329-342, 2014. DOI |
23 | Chassaing, B., Aitken, J.D., Malleshappa, M., et al. Dextran sulfate sodium (DSS)-induced colitis in mice.Current protocols in immunology. edited by John EColigan [et al] 104: Unit 15 25, 2014. |
24 | Ordas, I., Eckmann, L., Talamini, M., et al. Ulcerativecolitis. Lancet 380: 1606-1619, 2012. DOI |
25 | Alex, P., Zachos, N.C., Nguyen, T., et al. Distinct cytokine patterns identified from multiplex profiles ofmurine DSS and TNBS-induced colitis. Inflammatory bowel diseases 15: 341-352, 2009. DOI |
26 | Coskun, M., Salem, M., Pedersen, J., et al. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacological research : the official journal of the Italian Pharmacological Society 76: 1-8, 2013. DOI |
27 | Plevy, S. A STAT need for human immunologic studies to understand inflammatory bowel disease. The American journal of gastroenterology 100: 73-74, 2005. DOI |
28 | Adams, S.M., Bornemann, P.H. Ulcerative colitis. American family physician 87: 699-705, 2013. |
29 | Nielsen, O.H. New strategies for treatment of inflammatory bowel disease. Frontiers in medicine 1: 3, 2014. DOI |
30 | Atreya, R., Neurath, M.F. New therapeutic strategies for treatment of inflammatory bowel disease. Mucosal immunology 1: 175-182, 2008. DOI |
31 | Sandborn, W.J., Ghosh, S., Panes, J., et al. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerativecolitis. The New England journal of medicine 367: 616-624, 2012. DOI |
32 | Iraha, A., Chinen, H., Hokama, A., et al. Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1. World Journal of Gastroenterology, 2013. |
33 | Lu, S.W., Liu, H.J., Zhao, W., et al. Molecular mechanisms involved in the treatment of inflammatory bowel disease by Pulsatilla decoction. Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 27: 106-109, 2011. |
34 | You, Y., Liu, Y.H., Gao, S.L. Effect and Mechanism of Shenling Baizhu San on the Murine Model of Inflammatory Bowel Disease Induced by Dextran Sodium Sulfate in Mice. Chinese Journal of Experimental Traditional Medical Formulae 18: 136-140, 2012. |
35 | Qian, W., Wentao, F. Effect of Purslane Polysaccharide on Ulcerative Colitis Associated Colorectal Cancer and IL-6/STAT3 Pathway. World Chinese Medicine 8: 1256-1260, 2013. |
36 | Chuan-zi, D., Hui, F., Xiao, Z., et al. Thinking on Functional Mechanism of Acupuncture for Inflammatory Bowel Diseases Based on Metabolomics. Journal of Acupuncture and Tuina Science, 2014. |
37 | Kumar, V.S., Rajmane, A.R., Adil, M., et al. Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats. Journal of Biomedical Research, 2014. |
38 | Rajasekaran, S.A. Therapeutic potential of curcumin in gastrointestinal diseases. World Journal of Gastrointestinal Pathophysiology, 2011. |
39 | Ling, X.H., Yu, X., Kong, D.J., et al. Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enema. Chin J Integr Med 16: 222-228, 2010. DOI |
40 | Schneider, A., Streitberger, K., Joos, S. Acupuncture treatment in gastrointestinal diseases: A systematic review. World Journal of Gastroenterology, 2007. |
41 | Bravo, H.R., Copaja, S.V., Figueroa-Duarte, S., et al. 1,4-benzoxazin-3-one, 2-benzoxazolinone and gallic acid from Calceolaria thyrsiflora Graham and their antibacterial activity. Zeitschrift fur Naturforschung C, Journal of biosciences 60: 389-393, 2005. |
42 | Panes, J., Su, C., Bushmakin, A.G., et al. Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes. BMC gastroenterology 15: 14, 2015. DOI |
43 | Jayamani, J., Shanmugam, G. Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation. European journal of medicinal chemistry 85: 352-358, 2014. DOI |
44 | Wang, K., Zhu, X., Zhang, K., et al. Investigation of gallic acid induced anticancer effect in human breast carcinoma MCF-7 cells. Journal of biochemical and molecular toxicology 28: 387-393, 2014. DOI |
45 | Kim, Y.J. Antimelanogenic and antioxidant properties of gallic acid. Biological & pharmaceutical bulletin 30: 1052-1055, 2007. DOI |
46 | Zhao, B., Hu, M. Gallic acid reduces cell viability, proliferation, invasion and angiogenesis in human cervical cancer cells. Oncology letters 6: 1749-1755, 2013. DOI |
47 | Hsiang, C.Y., Hseu, Y.C., Chang, Y.C., et al. Toona sinensis and its major bioactive compound gallic acid inhibit LPS-induced inflammation in nuclear factor-kappaB transgenic mice as evaluated by in vivo bioluminescence imaging. Food chemistry 136: 426-34, 2013. DOI |
48 | Ukil, A., Maity, S., Das, P.K. Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation. British journal of pharmacology 149: 121-31, 2006. DOI |
49 | Wang, X.J., Deng, H.Z., Jiang, B., et al. The natural plant product sophocarpine ameliorates dextran sodium sulfate-induced colitis in mice by regulating cytokine balance. International journal of colorectal disease 27: 575-581, 2012. DOI |
50 | Liu, L., Liu, Y.L., Liu, G.X., et al. Curcumin ameliorates dextran sulfate sodium-induced experimental colitis by blocking STAT3 signaling pathway. International immunopharmacology 17: 314-320, 2013. DOI |
51 | Anthoni, C., Laukoetter, M.G., Rijcken, E., et al. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitis. American journal of physiology Gastrointestinal and liver physiology 290: G1131-G1137, 2006. DOI |
52 | Piberger, H., Oehme, A., Hofmann, C., et al. Bilberries and their anthocyanins ameliorate experimental colitis. Molecular nutrition & food research 55: 1724-1729, 2011. DOI |
53 | Khanavi, M., Sabbagh-Bani-Azad, M., Abdolghaffari, A.H., et al. On the benefit of galls of Quercus brantii Lindl. in murine colitis: the role of free gallic acid. Archives of medical science : AMS 10: 1225-1234, 2014. DOI |
54 | Pandurangan, A.K., Mohebali, N., Mohd Esa, N., et al. Gallic acid suppresses inflammation in dextran sodium sulfate-induced colitis in mice: Possible mechanisms. International immunopharmacology 28: 1034-1043, 2015. DOI |
55 | Pandurangan, A.K., Mohebali, N., Norhaizan, M.E., et al. Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice. Drug Des Devel Ther 9: 3923-3934, 2015. DOI |